Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis.
Sabrina HabenAndrea I CipleaMarianne TokicNina TimmesfeldSandra ThielRalf GoldAnnette Magdalene Langer-GouldKerstin HellwigPublished in: Journal of neurology, neurosurgery, and psychiatry (2023)
In active MS, an early postpartum treatment strategy should be determined well before delivery. Natalizumab/fingolimod-strategy reduced postpartum relapse hazard from month 3, but none diminished the early postpartum relapse hazard.
Keyphrases